Non-injection drug use and Hepatitis C Virus: a systematic review.
about
Syphilis in drug users in low and middle income countriesInstruments used to evaluate smoking habits: a systematic reviewHepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort StudiesHCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, ChinaThe Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in ChinaBaseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment ProgramHIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, CaliforniaUsing qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.The HCV Synthesis Project: scope, methodology, and preliminary results.A trial to reduce hepatitis C seroincidence in drug users.Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injectionBinge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego.Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern AmazonRisk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studiesHepatitis C virus infection in Brazilian long-distance truck drivers.HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions.Exploring sex differences in drug use, health and service use characteristics among young urban crack users in BrazilA cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.Crack pipe sharing among street-involved youth in a Canadian setting.Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study."We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada.Reducing widespread pipe sharing and risky sex among crystal methamphetamine smokers in Toronto: do safer smoking kits have a potential role to play?Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.Hepatitis C virus-specific immune responses in noninjecting drug users.Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control StudyOn-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco.A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groupsThe HCV care continuum among people who use drugs: protocol for a systematic review and meta-analysisCritical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusersHIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug UsersMeta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.Comparing key characteristics of young adult crack users in and out-of-treatment in Rio de Janeiro, Brazil
P2860
Q22252231-4751B0B5-58B2-45D8-B13A-FAF5617549C5Q27027805-2A45EF43-AB10-4324-AA35-51D1514F0240Q27488500-EDEABD77-D412-4689-8E71-97355FB54939Q27489900-ADE2501C-1783-4860-A9E4-196CD0EAD980Q28483942-E3C7FCE2-0506-4559-9C1A-536265EC0BA9Q28550281-3EBBF80E-5D8F-466F-8208-ACB704413C0DQ28550339-6191E244-E9DE-44EC-BA72-282851D41DDAQ30226766-A595B1D1-09DE-4F10-B640-45EE2C9E94C6Q30250088-F6DD3464-F1D6-4E83-9EEB-E4501AC499E5Q30837913-5D24FCA9-AE7E-4F31-9FF5-B31437AAE154Q30873859-DD61855D-F751-4CFF-A842-BD85CE2FE4C3Q33369233-D9A58EC7-38CB-47B3-8EC3-94C6ED882E64Q33658861-F8D0B6D7-7F49-4564-9D55-6E76CFFEB4FBQ33760646-3A6BCE11-605C-4B2C-B8F9-7E35F6B7EDB1Q33819756-91A89C29-F9F7-4F2D-A9D3-882E7E72DD9AQ33828630-510C58EF-C1F2-4E07-BB8A-B8469A2E0E3DQ33872878-257372DA-6443-40BC-8F15-6268DAA0A076Q34128275-776907CF-9639-42C1-B318-D246AB7DC0A0Q34365104-57EAD9DA-0C63-4501-B764-46545237B485Q34570190-BB3B9D3D-2FBD-4CF6-9067-A2C38BE5F4F9Q34611579-8D849043-DFC9-41A7-AF0C-D11D4FB73CA1Q35009748-22619EB3-198B-4463-B17D-F0694D846C35Q35083912-40FEE100-F95D-4E47-8278-372B7696D995Q35640049-E362C71A-7CDA-474C-B99B-2AE42CC55878Q35744236-BF803125-39F0-4991-8501-78DD9C74360FQ35837545-64F05BCC-D777-4044-88CC-127E543CA71BQ36005257-9DD4A3B5-4312-48D2-AADC-B95B6054A6B4Q36208809-E0F4E7A8-ADC2-44AF-9C03-79741C60862EQ36334818-65D095EE-31BC-498E-B3CA-13316FD5A23AQ36646287-F146AB75-0BD7-45F0-82CB-41179EC55203Q36845718-530A8A10-BA0F-4BCC-AFBA-0404D4E540FDQ36878938-1CF36547-80DE-49F9-856D-19DA4D38B0D7Q36975130-6FA173D1-18FE-49AB-B4DD-6C057B1AAF64Q37031381-774ED424-A5EB-424F-B845-CD718634F6D4Q37084628-5A38B97E-BCAC-4A85-BA73-8269CA18FBC1Q37142229-26D3FA5C-3280-4C6B-A77B-85AA0D38157EQ37298826-1C48C4B4-55D5-4126-9F9D-5481643B3B26Q37305713-D946FA6C-A212-457D-BCED-B46F99E17597Q37306146-A9FBE3E2-FD55-4592-A3BC-22D720C7A7BBQ37497055-2136CC32-424E-4B4F-B5DE-9ED7BB5E2488
P2860
Non-injection drug use and Hepatitis C Virus: a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Non-injection drug use and Hepatitis C Virus: a systematic review.
@ast
Non-injection drug use and Hepatitis C Virus: a systematic review.
@en
type
label
Non-injection drug use and Hepatitis C Virus: a systematic review.
@ast
Non-injection drug use and Hepatitis C Virus: a systematic review.
@en
prefLabel
Non-injection drug use and Hepatitis C Virus: a systematic review.
@ast
Non-injection drug use and Hepatitis C Virus: a systematic review.
@en
P2093
P2860
P31
P921
P1476
Non-injection drug use and Hepatitis C Virus: a systematic review.
@en
P2093
Corina Lelutiu-Weinberger
Don C Des Jarlais
Peter L Flom
Rebecca Stern
Roberta Scheinmann
P2860
P356
10.1016/J.DRUGALCDEP.2006.11.014
P577
2006-12-15T00:00:00Z
2007-06-15T00:00:00Z